spacer
home > contact us
CONTACT US


   

Address

Samedan Ltd

Suite E, 11 Bell Yard Mews

175 Bermondsey Street

London

SE1 3TN




Email

info@samedanltd.com




Telephone Number

+44 (0)20 7724 3456




Fax Number

+44 (0)20 7403 7747




Subscriptions and Data Management

Beeline Data Services Ltd

Tel: 01342 312593

Fax: 01342 770131

Email: samedan@beelinedata.co.uk

www.beelinedata.co.uk





Rights / Permissions

Welcome to Samedan’s permissions enquiry page.

For all permissions requests to reuse content from Samedan Ltd are now being processed through PLSclear.

Search for the article you wish to use by title, author name, article title, author name, Article No or Company; complete
the following form with as much information as possible;
and submit. We will respond as quickly as possible (info@samedanltd.com)




spacer

Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

News and Press Releases

Huge boom in Korean Pharma reported at CPhI Korea

Amsterdam, 19th September 2019: The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders Association (KPTA) – has seen a surge in growth across domestic and international pharma companies, as well as a sizable rise in overall attendees. As reported earlier this year in the provisional findings of the CPhI Pharma Index[1], Korea has seen a rapid growth in its international reputation (seeing its ‘overall competitiveness’ rise 14% in the last two years), which is now translating into a sizable growth in the market and at the event.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement